Figure S10. Serum level comparison. Comparison of levels of serum PD-1 and PD-L1 between patients with sepsis and healthy controls. (DOCX 175Â kb
Background: Sepsis remains a major cause of mortality in critical care, for which specific treatment...
Table S1. Demographic characteristics of patients in both study phases. (DOCX 16 kb
Leukocyte counts in survivors and non-survivors for the first 7Â days following sepsis diagnosis. (P...
Figure S11. Serum versus cell surface expression. Serum levels of PD-1 and PD-L1 are plotted against...
Figure S9. Comparison by survival status. Comparison of PD-1, PD-L1 and PD-L2 expression by B and CD...
Figure S6. Comparison by nosocomial infection status. Comparison of expression of PD-1, PD-L1 and PD...
Figure S4. CD4+ T cell subset MFI. Comparison of expression of PD-1, PD-L1 and PD-L2 as determined b...
Table S6. sPD-1/sPD-L1 studies in sepsis. Summary of previous studies measuring soluble serum PD-1 a...
Table S5. MFI of PD-1, PD-L1 and PD-L2 on CD27+ B cells, CD27- B cells, CD27+ CD4+ T cells and CD27-...
Figure S3. B cell percentage positivity. Comparison of the expression levels as determined by percen...
Table S4. Proportion of positive cells by CD27 expression status. Proportion of CD27+ B cells, CD27-...
Figure S2. B cell subset MFI. Comparison of expression of PD-1, PD-L1 and PD-L2 as determined by MFI...
Table S1. Characteristics of patients with sepsis included in the study. Results are shown for all p...
Table S2. Survival status, microbiology results and nosocomial infection site in patients who develo...
Figure S8. Comparison by nosocomial infection status in patients with ICU length of stay ≥7 days. Co...
Background: Sepsis remains a major cause of mortality in critical care, for which specific treatment...
Table S1. Demographic characteristics of patients in both study phases. (DOCX 16 kb
Leukocyte counts in survivors and non-survivors for the first 7Â days following sepsis diagnosis. (P...
Figure S11. Serum versus cell surface expression. Serum levels of PD-1 and PD-L1 are plotted against...
Figure S9. Comparison by survival status. Comparison of PD-1, PD-L1 and PD-L2 expression by B and CD...
Figure S6. Comparison by nosocomial infection status. Comparison of expression of PD-1, PD-L1 and PD...
Figure S4. CD4+ T cell subset MFI. Comparison of expression of PD-1, PD-L1 and PD-L2 as determined b...
Table S6. sPD-1/sPD-L1 studies in sepsis. Summary of previous studies measuring soluble serum PD-1 a...
Table S5. MFI of PD-1, PD-L1 and PD-L2 on CD27+ B cells, CD27- B cells, CD27+ CD4+ T cells and CD27-...
Figure S3. B cell percentage positivity. Comparison of the expression levels as determined by percen...
Table S4. Proportion of positive cells by CD27 expression status. Proportion of CD27+ B cells, CD27-...
Figure S2. B cell subset MFI. Comparison of expression of PD-1, PD-L1 and PD-L2 as determined by MFI...
Table S1. Characteristics of patients with sepsis included in the study. Results are shown for all p...
Table S2. Survival status, microbiology results and nosocomial infection site in patients who develo...
Figure S8. Comparison by nosocomial infection status in patients with ICU length of stay ≥7 days. Co...
Background: Sepsis remains a major cause of mortality in critical care, for which specific treatment...
Table S1. Demographic characteristics of patients in both study phases. (DOCX 16 kb
Leukocyte counts in survivors and non-survivors for the first 7Â days following sepsis diagnosis. (P...
DOI
Add to ORKG